STOCK TITAN

Niki BioSolutions CFO holds options on 75,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

Niki BioSolutions, Inc. Chief Financial Officer Thomas John Freeburg reported directly held options covering 75,000 common shares, granted September 1, 2026, at an exercise price of $8.83 per share. Vesting includes 15,000 upon filing the issuer’s first full annual report after the merger; 20,000 in equal quarterly installments over eight quarters following September 1, 2026; 15,000 upon $5 million in cumulative capital investments; and 25,000 upon a change in control. Unvested options accelerate upon a change in control, subject to the equity incentive plan.

Insider Freeburg Thomas John
Role Chief Financial Officer
Type Security Shares Price Value
Holding Stock Options F1 -- -- --
Holdings: Stock Options — 75,000 options (Direct)
Footnotes (1)
  1. F1. Represents options to purchase an aggregate of 75,000 shares of the Issuer's common stock, granted on September 1, 2026, at an exercise price of $8.83 per share, of which (i) 15,000 vest upon the filing of the Issuer's first full Annual Report following the merger, (ii) 20,000 vest in equal quarterly installments over eight quarters following September 1, 2026, (iii) 15,000 vest upon the Issuer raising an aggregate of $5,000,000 in cumulative capital investments, and (iv) 25,000 vest upon a change in control of the Issuer. All unvested options will accelerate and vest upon a change in control, subject to the terms of the applicable equity incentive plan.
Options covering common shares 75,000 shares Directly held options reported by Chief Financial Officer Thomas John Freeburg
Exercise price $8.83 per share Options granted September 1, 2026
Annual-report vesting tranche 15,000 options Vests upon filing the issuer’s first full annual report following the merger
Quarterly vesting tranche 20,000 options Vests in equal quarterly installments over eight quarters following September 1, 2026
Quarterly vesting period Eight quarters Installments follow September 1, 2026
Capital-investment vesting tranche 15,000 options Vests upon the issuer raising $5 million in cumulative capital investments
Cumulative capital-investment threshold $5 million Condition for vesting of 15,000 options
Change-in-control vesting tranche 25,000 options Vests upon a change in control
stock options technical
"options to purchase an aggregate of 75,000 shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vesting financial
"20,000 vest in equal quarterly installments over eight quarters"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
change in control financial
"upon a change in control of the Issuer"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
equity incentive plan financial
"subject to the terms of the applicable equity incentive plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When do Thomas John Freeburg’s NIKI options expire?

The options expire on September 1, 2036.

What happens to unvested NIKI options upon a change in control?

All unvested options accelerate and vest upon a change in control, subject to the terms of the applicable equity incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Freeburg Thomas John

(Last)(First)(Middle)
C/O NIKI BIOSOLUTIONS, INC.
116 VILLAGE BOULEVARD, SUITE 200

(Street)
PRINCETON NEW JERSEY 08540

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
10/09/2026
3. Issuer Name and Ticker or Trading Symbol
Niki BioSolutions, Inc. [ NIKI ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (1)09/01/2036Common Stock75,000(1)$8.83D
Explanation of Responses:
1. Represents options to purchase an aggregate of 75,000 shares of the Issuer's common stock, granted on September 1, 2026, at an exercise price of $8.83 per share, of which (i) 15,000 vest upon the filing of the Issuer's first full Annual Report following the merger, (ii) 20,000 vest in equal quarterly installments over eight quarters following September 1, 2026, (iii) 15,000 vest upon the Issuer raising an aggregate of $5,000,000 in cumulative capital investments, and (iv) 25,000 vest upon a change in control of the Issuer. All unvested options will accelerate and vest upon a change in control, subject to the terms of the applicable equity incentive plan.
/s/ Thomas John Freeburg11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading